Fulgent Genetics Inc (FLGT)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Fulgent Genetics Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 5 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 16.60 $ — 16% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
6 of 10 Solid growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years -19.5% failed
- More than 10% revenue growth is expected for the coming year 14.6% passed
- Share count grows by less than 3% a year -0.2% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") -24.7% failed
- Gross margin at 40% or higher and without meaningful erosion 40.6% passed
- Goodwill from acquisitions does not grow faster than revenue 2.1% passed
- Net debt below twice EBITDA 328 m net cash passed
- Operating cash flow covers the profits of the last three years 217 m failed
- Return on capital at 15% or higher, or up versus two years ago -8.1% failed
- Insiders hold at least 10% or are net buyers 36.7% passed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 9.6% below the current price.
- Consensus
- Hold
- Analyst Ratings
- 3
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | -1.57 | -1.59 – -1.55 | 351 | -473.4% | 2 |
| 12/31/2027 | -1.53 | -1.91 – -1.15 | 402 | 2.6% | 2 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.19 | – | 76 | 8.10 | -7.70 | 25 | 21 |
| 2025: Q1 | -0.37 | – | 74 | 13.90 | -15.70 | -4 | -9 |
| 2025: Q2 | -0.61 | – | 82 | 15.20 | -23.20 | -30 | -37 |
| 2025: Q3 | -0.21 | – | 84 | 17.20 | -7.90 | 11 | 5 |
| 2025: Q4 | -0.76 | – | 83 | 9.30 | -28.10 | -78 | -83 |
| 2026: Q1 | -0.80 | – | 71 | -3.20 | -34.90 | 7 | 2 |
| 2026: Q2 | – | – | 85 | 4.40 | -34.50 | -24 | -28 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 18 | 1 | -5 | -0.30 | 4 | 54 | 58 |
| 2017 | 19 | -3 | -3 | -0.15 | 1 | 54 | 57 |
| 2018 | 21 | -5 | -4 | -0.25 | -1 | 52 | 55 |
| 2019 | 33 | 0 | 0 | 0.02 | 6 | 83 | 89 |
| 2020 | 422 | 290 | 214 | 8.91 | 141 | 569 | 700 |
| 2021 | 993 | 104 | 104 | 3.37 | 539 | 1,159 | 1,279 |
| 2022 | 619 | 179 | 143 | 4.63 | 254 | 1,267 | 1,386 |
| 2023 | 289 | -196 | -168 | -5.63 | 27 | 1,136 | 1,235 |
| 2024 | 283 | -74 | -43 | -1.41 | 21 | 1,133 | 1,220 |
| 2025 | 323 | -91 | -61 | -1.97 | -102 | 1,112 | 1,214 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally.
| Employees | 1,315 |
|---|---|
| Headquarters | El Monte, CA |
| Address | 4399 Santa Anita Avenue, 91731 El Monte, United States |
| Phone | 626 350 0537 |
| Website | fulgentgenetics.com |
| IPO Date | 29. Sep 2016 |
| ISIN | US3596641098 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Ming Hsieh | Chairman & CEO | 1956 |
| Jian Xie | COO & President | 1966 |
| Paul Kim CPA | Chief Financial Officer | 1967 |
| Hanlin Gao D.A.B.M.G., FACMG, M.D., Ph.D. | Chief Scientific Officer & Lab Director | 1967 |
| Natalie Prescott CIPM, CIPP | General Counsel & Chief Privacy Officer | – |
| Doreen Ng | Vice President of Operations & Compliance | – |
| Jakub Sram | Vice President of Business Development & Sales | – |
| Ellen Tsui | Vice President of Human Resources | – |
| Brandon Perthuis | Chief Commercial Officer | – |
| Elias Nyankojo | Chief Information Security Officer | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 26. Jul 2026 | Kim Paul | CFO and Treasurer | Other | 2,747 | 19.67 | 54,033 |
| 26. Jul 2026 | Xie Jian | President and COO | Other | 4,361 | 19.67 | 85,781 |
| 26. Jul 2026 | Gao Hanlin | Chief Scientific Officer | Other | 1,645 | 19.67 | 32,357 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.